FOR PHARMACISTS · REFERENCE EDITION 8.0261 monographs · 32 SOPs · 18 forms

SOP-004 / SOP v2.0

Suppliers, receipt and raw materials

Active substances, excipients, commercial products and packaging materials.

Procedure

  1. Qualify suppliers for identity, quality, traceability and recall capability. Define an appropriate pharmacopoeial or other justified specification.
  2. At receipt check the name, salt/hydrate form, lot, integrity, quantity, expiry and transport conditions.
  3. Match the CoA and SDS to the exact lot/material. Assess identity, assay and critical impurities; the document title alone is insufficient.
  4. Quarantine until the required review is complete. Record acceptance or rejection by an authorised person.
  5. Label opening date, conditions and any justified in-use period. Segregate allergens and incompatible materials.
  6. Maintain inventory and lot movements using earliest-expiry priority. Every substitution or supplier change enters change control.

Edition-specific detail

F-017 records exact chemical form, compendial grade, supplier, lot, CoA, SDS, transport conditions and quarantine/release decision. Potency or water corrections use the actual CoA and formulation instructions. A retest date is not automatically an expiry date.

Stop criterion

Uncertain identity, unacceptable transport or missing critical data: quarantine.

Related forms

F-017, F-007

Sources and references

  1. NAPRA — Model Standards for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 4–9Risk, personnel, facilities and QA; its historical BUD table is not used for current USP defaults2026-09-12
  2. NAPRA — Guidance Document for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 5, 6 and 7; master/batch records, delivery, qualityQuality-system implementation; historical BUD table not substituted for 2022 USP revision2026-09-12
  3. PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12